Sam leads a global team of seasoned scientists with extensive regulatory and scientific experience in drug development. With over 25 years of experience, he collaborates with pharmaceutical and biotechnology companies worldwide, by creating, advising, and monitoring nonclinical regulatory safety drug and medical device development programs. He provides expertise covering a wide range of drug classes (new chemical and biological entities, advanced therapies, etc.), medical devices, and therapeutic areas.